Anixa Biosciences (ANIX) Assets (2010 - 2026)
Anixa Biosciences (ANIX) posted Assets of $15.07 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 14.6% from $17.65 million a year earlier but up 1.4% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Anixa Biosciences' Assets came in at $16.08 million, down 25.5% from FY2024.
- Annual Assets has declined for four consecutive fiscal years, though with a five-year compound annual growth rate of 11.2% (FY2020 to FY2025).
- In prior fiscal years, Anixa Biosciences' Assets was $21.59 million in FY2024 (-15.4%), $25.52 million in FY2023 (-16.1%), $30.41 million in FY2022 (-16.1%) and $36.26 million in FY2021 (+283.6%).
- Quarterly Assets has run from a low of $14.87 million in fiscal Q2 2026 to a high of $36.26 million in fiscal Q4 2021 over five years.
- The strongest year-over-year quarter for Assets in the past five years was fiscal Q4 2021, with growth of 283.6%; the weakest was fiscal Q2 2025, with a decline of 30.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | 15.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 15.07 Mn |
| Apr 30, 2026 | 14.87 Mn |
| Oct 31, 2025 | 16.08 Mn |
| Jul 31, 2025 | 17.65 Mn |
| Apr 30, 2025 | 16.98 Mn |
| Jan 31, 2025 | 18.91 Mn |
| Oct 31, 2024 | 21.59 Mn |
| Jul 31, 2024 | 22.91 Mn |
| Apr 30, 2024 | 24.36 Mn |
| Jan 31, 2024 | 25.37 Mn |
| Oct 31, 2023 | 25.52 Mn |
| Jul 31, 2023 | 26.58 Mn |
| Apr 30, 2023 | 27.60 Mn |
| Jan 31, 2023 | 28.31 Mn |
| Oct 31, 2022 | 30.41 Mn |
| Jul 31, 2022 | 32.56 Mn |
| Apr 30, 2022 | 32.80 Mn |
| Jan 31, 2022 | 35.24 Mn |
| Oct 31, 2021 | 36.26 Mn |
| Jul 31, 2021 | 37.06 Mn |
API Access
Anixa Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();